BBM-H901 was shown to significantly reduce bleeding rates among hemophilia B patients in clinical trials, a new study in China shows.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback